Insulin inhibits NFκB and MCP-1 expression in human aortic endothelial cells

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 1, 2001, Pages 450-453

  Aljada, A ^a   Ghanim, H ^a   Saadeh, R ^a   Dandona, P ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1;

AORTA; ARTICLE; ATHEROGENESIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENDOTHELIUM CELL; HORMONE ACTION; HUMAN; HUMAN CELL; INFLAMMATION; LEUKOCYTE ACTIVATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; CELL CULTURE; CYTOLOGY; DRUG ANTAGONISM; METABOLISM; VASCULAR ENDOTHELIUM;

AORTA; CELLS, CULTURED; CHEMOKINE CCL2; ENDOTHELIUM, VASCULAR; HUMANS; INSULIN; NF-KAPPA B;

EID: 0034746443     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.86.1.450     Document Type: Article

References (26)

1. Insulin inhibits the expression of ICAM-1 by human aortic endothelial cells through stimulation of nitric oxide
2. Increased ICAM-1 expression in aortic disease
3. Plasma concentration of soluble intercellular adhesion molecule 1 and risks of future myocardial infarction in apparently healthy men
4. Atherosclerosis-an inflammatory disease
5. Hyperinsulinemia and atherosclerosis
6. Relative contribution of insulin and its precursors to fibrinogen and PAI-1 in a large population with different states of glucose tolerance. The Insulin Resistance Atherosclerosis Study (IRAS)
7. Insulin-mediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release
8. Beta adrenergic-mediated vasodilator response to insulin in the human forearm
9. Nitric oxide release accounts for insulin's vascular effects in humans
10. Insulin-induced vasodilation of internal carotid artery
11. Insulin attenuates norepinephrine-induced venoconstriction. An ultrasonographic study
12. Insulin-mediated vasodilation and impairment with increased blood pressure and body mass
13. Insulin-stimulated production of nitric oxide is inhibited by wortmannin. Direct measurement in vascular endothelial cells
14. Effect of insulin on human aortic endothelial nitric oxide synthase
15. Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3′ 5′-cyclic monophosphate and adenosine-3′ 5′-cyclic monophosphate
16. NF-kappa B: Ten years after
17. Mapping of the inducible IkappaB phosphorylation sites that signal its ubiquitination and degradation
18. Transcriptional regulation of the human monocyte chemoattractant protein-1 gene. Cooperation of two NF-kappaB sites and NF-kappaB/Rel subunit specificity
19. Monocyte chemoattractant protein-1
20. Expression of monocyte chemoattractant protein-1 in vascular tissue
21. Inhibition of NF-kappa B by sodium salicylate and aspirin
22. Glucocorticoid-mediated repression of nuclear factor-kappaB-dependent transcription involves direct interference with transactivation
23. Increased IkappaB expression and diminished nuclear NF-kappaB in human mononuclear cells following hydrocortisone injection
24. Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells and in vivo: A specific vascular action of insulin
25. Biology and biochemistry of the chemokines: A family chemotactic and inflammatory cytokines
26. Insulin inhibits ROS generation, p47phox and NFkB in mononuclear cells and reduces plasma sICAM-1 and MCP-1 in obese subjects